Real world evidence (RWE) - Are we (RWE) ready?
Perspectives in Clinical Research, 2018 Real world evidence is important as it complements data from randomised controlled trials (RCTs). Both have limitations in design, interpretation, and extrapolatability. It is imperative one designs real world studies in the right way, else it can be misleading.
Viraj Ramesh Suvarna
exaly +5 more sources
Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies [PDF]
Journal of Market Access & Health PolicyBackground: Real-world evidence (RWE) can complement clinical trials to inform health technology assessments (HTAs). This study examined the extent to which RWE is considered in HTAs of non-oncology orphan medicinal products across six agencies globally.
Oliver Blandy +5 more
doaj +2 more sources
Mapping the Use of Real-World Evidence Across the EU Health Technology Assessment Regulation: Methodological Considerations, Challenges, and Opportunities for Harmonization [PDF]
Journal of Market Access & Health PolicyMethodological guidelines for real-world evidence (RWE) in European Union (EU) joint clinical assessments (JCA) are lacking. This manuscript explores RWE potential in EU health technology assessment (HTA) and offers recommendations for generating high ...
Grammati Sarri +4 more
doaj +2 more sources
AMA- and RWE- Based Adaptive Kalman Filter for Denoising Fiber Optic Gyroscope Drift Signal
Sensors, 2015 An improved double-factor adaptive Kalman filter called AMA-RWE-DFAKF is proposed to denoise fiber optic gyroscope (FOG) drift signal in both static and dynamic conditions.
Gongliu Yang, Yang Gongliu
exaly +3 more sources
RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design
Drugs - Real World Outcomes, 2019 Objectives Real-world evidence (RWE) is essential for the development of pharmaceutical and medical technologies and informs treatment-related decisions by regulatory agencies, payers, healthcare providers, and patients.
Andrew Xia +2 more
exaly +3 more sources
The unregulated majority: who ensures quality in non-submission real-world studies? [PDF]
Frontiers in MedicineReal-world evidence (RWE) plays an increasingly important role in healthcare decision-making, yet most industry-sponsored RWE studies are not intended for regulatory or reimbursement submission.
Alexandros Sagkriotis +1 more
doaj +2 more sources
Advancing real-world evidence in Brazil: regulatory gaps and global lessons [PDF]
The Lancet Regional Health. AmericasSummary: Regulatory agencies are increasingly incorporating real-world data (RWD) and real-world evidence (RWE) into decision-making frameworks to complement randomized clinical trials. While some regions, such as the U.S.
Nélio Cézar de Aquino +7 more
doaj +2 more sources
Journal of Market Access & Health Policy, 2023 Background The economic consequences of the recent COVID-19 pandemic were substantial. However, direct medical costs in France have not been determined.Objective To describe patient characteristics, intensity of care, mortality, and direct medical costs ...
Claire Leboucher +7 more
doaj +1 more source
Journal of Pharmacy & Pharmaceutical Sciences, 2022 Purpose: Between January 2020 and December 2021, Health Canada provided a Summary Basis of Decision (SBD) for each of 110 products approved, including 29 oncology products and 21 non-oncology orphan drugs.
Catherine Lau +2 more
doaj +1 more source
How can real‐world evidence aid decision making during the life cycle of nonprescription medicines?
Clinical and Translational Science, 2022 Real‐world evidence (RWE) is an emerging scientific discipline which is being increasingly utilized for decision making on prescription‐only medicines.
Emese Csoke +5 more
doaj +1 more source